Limited Mitochondrial Activity Coupled With Strong Expression of CD34, CD90 and EPCR Determines the Functional Fitness of ex vivo Expanded Human Hematopoietic Stem Cells
Copyright © 2020 Papa, Djedaini, Martin, Zangui, Beaumont, Sebra, Parsons, Schaniel and Hoffman..
Ex vivo expansion strategies of human hematopoietic stem cell (HSC) grafts with suboptimal stem cell dose have emerged as promising strategies for improving outcomes of HSC transplantation in patients with hematological malignancies. While exposure of HSCs to ex vivo cultures expands the number of phenotypically identifiable HSCs, it frequently alters the transcriptomic and metabolic profiles, therefore, compromising their long-term (LT) hematopoietic reconstitution capacity. Within the heterogeneous pool of expanded HSCs, the precise phenotypic, transcriptomic and metabolic profile and thus, the identity of HSCs that confer LT repopulation potential remains poorly described. Utilizing valproic acid (VPA) in ex vivo cultures of umbilical cord blood (UCB)-CD34+ cells, we demonstrate that expanded HSCs phenotypically marked by expression of the stem cell markers CD34, CD90 and EPCR (CD201) are highly enriched for LT-HSCs. Furthermore, we report that low mitochondrial membrane potential, and, hence, mitochondrial activity distinguishes LT-HSCs within the expanded pool of phenotypically defined HSCs. Remarkably, such reduced mitochondrial activity is restricted to cells with the highest expression levels of CD34, CD90 and EPCR phenotypic markers. Together, our findings reveal that high expression of CD34, CD90 and EPCR in conjunction with low mitochondrial activity is critical for identification of functional LT-HSCs generated within ex vivo expansion cultures.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Frontiers in cell and developmental biology - 8(2020) vom: 18., Seite 592348 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Papa, Luena [VerfasserIn] |
---|
Links: |
---|
Themen: |
CD90 |
---|
Anmerkungen: |
Date Revised 03.01.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fcell.2020.592348 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319490343 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319490343 | ||
003 | DE-627 | ||
005 | 20231225171543.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fcell.2020.592348 |2 doi | |
028 | 5 | 2 | |a pubmed24n1064.xml |
035 | |a (DE-627)NLM319490343 | ||
035 | |a (NLM)33384995 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Papa, Luena |e verfasserin |4 aut | |
245 | 1 | 0 | |a Limited Mitochondrial Activity Coupled With Strong Expression of CD34, CD90 and EPCR Determines the Functional Fitness of ex vivo Expanded Human Hematopoietic Stem Cells |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 03.01.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2020 Papa, Djedaini, Martin, Zangui, Beaumont, Sebra, Parsons, Schaniel and Hoffman. | ||
520 | |a Ex vivo expansion strategies of human hematopoietic stem cell (HSC) grafts with suboptimal stem cell dose have emerged as promising strategies for improving outcomes of HSC transplantation in patients with hematological malignancies. While exposure of HSCs to ex vivo cultures expands the number of phenotypically identifiable HSCs, it frequently alters the transcriptomic and metabolic profiles, therefore, compromising their long-term (LT) hematopoietic reconstitution capacity. Within the heterogeneous pool of expanded HSCs, the precise phenotypic, transcriptomic and metabolic profile and thus, the identity of HSCs that confer LT repopulation potential remains poorly described. Utilizing valproic acid (VPA) in ex vivo cultures of umbilical cord blood (UCB)-CD34+ cells, we demonstrate that expanded HSCs phenotypically marked by expression of the stem cell markers CD34, CD90 and EPCR (CD201) are highly enriched for LT-HSCs. Furthermore, we report that low mitochondrial membrane potential, and, hence, mitochondrial activity distinguishes LT-HSCs within the expanded pool of phenotypically defined HSCs. Remarkably, such reduced mitochondrial activity is restricted to cells with the highest expression levels of CD34, CD90 and EPCR phenotypic markers. Together, our findings reveal that high expression of CD34, CD90 and EPCR in conjunction with low mitochondrial activity is critical for identification of functional LT-HSCs generated within ex vivo expansion cultures | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a CD90 | |
650 | 4 | |a EPCR | |
650 | 4 | |a ex vivo expansion | |
650 | 4 | |a functional fitness | |
650 | 4 | |a mitochondrial membrane potential | |
650 | 4 | |a phenotype | |
650 | 4 | |a valproic acid | |
700 | 1 | |a Djedaini, Mansour |e verfasserin |4 aut | |
700 | 1 | |a Martin, Tiphaine C |e verfasserin |4 aut | |
700 | 1 | |a Zangui, Mahtab |e verfasserin |4 aut | |
700 | 1 | |a Beaumont, Kristin G |e verfasserin |4 aut | |
700 | 1 | |a Sebra, Robert |e verfasserin |4 aut | |
700 | 1 | |a Parsons, Ramon |e verfasserin |4 aut | |
700 | 1 | |a Schaniel, Christoph |e verfasserin |4 aut | |
700 | 1 | |a Hoffman, Ronald |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in cell and developmental biology |d 2013 |g 8(2020) vom: 18., Seite 592348 |w (DE-627)NLM240031415 |x 2296-634X |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2020 |g day:18 |g pages:592348 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fcell.2020.592348 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2020 |b 18 |h 592348 |